Abstract:CLINICAL PRACTICE GUIDELINES (CPGS) ARE WIDELY viewed as a cornerstone of current efforts to improve the quality of clinical care. At their best, CPGs articulate clear goals of care, enumerate potentially beneficial therapeutic approaches, and may reduce undesirable variation in care while supporting rational clinical management of common conditions. Clinical recommendations are often supported by evidence from well-designed randomized trials when such information is available. The National Guideline Clearinghouse sponsored by the Agency for Healthcare Research and Quality listed about 650 CPGs in 1999 and more than 1650 active CPGs in July 2005. In the last several years, major evidence-based recommendations from CPGs have often been proposed as measures of quality of care. For example, McGlynn et al identified 439 disease-specific and preventive quality-of-care indicators, many of which reflect current care recommendations in CPGs. Others have proposed and federal law may soon mandate use of such quality measures to assess clinical performance for accountability purposes and for pay-forperformance initiatives. A wealth of evidence suggests that intensive management of diabetes, hypertension, dyslipidemias, and other chronic conditions is, on average, beneficial to broad groups of patients in terms of health outcomes. Most data are based on studies limited to a single clinical intervention, but several clinical trials that intensively managed multiple clinical domains also have shown unequivocal benefit. In one randomized trial of adults with type 2 diabetes, simultaneous intensive management of glucose levels, blood pressure, lipid levels, use of angiotensin-converting enzyme inhibitors, and use of aspirin led to a 53% reduction in major cardiovascular events over a 7.8-year period. However, in this issue of JAMA, Boyd and colleagues demonstrate that even the best evidence-based, disease-specific CPGs may lead to unintended consequences when used to help guide the care of elderly patients with multiple comorbid conditions. In reviewing national guidelines for 9 common chronic conditions, the authors note that 8 of the 9 CPGs failed to emphasize that benefits may vary significantly in relation to patient factors such as life expectancy. Five of these 9 CPGs failed to address the care of patients with multiple comorbid conditions, although comorbidity is common in elderly patients. About 83% of Medicare beneficiaries have at least 1 chronic condition, and about 68% of Medicare’s budget is devoted to the 23% of beneficiaries with 5 or more chronic conditions. Patients treated with multiple medications and multiple lifestyle interventions are at high risk of medical errors and nonadherance. Many patients described by Boyd et al would receive 10 or more distinct medications dosed at 3 to 5 times each day, along with more than a dozen nonpharmacological treatment recommendations. Such complex treatment regimens disrupt daily routines, impair social activities, and almost inevitably invite nonadherance. As shown by Boyd et al, medication costs may easily exceed $5000 per year. Even with forthcoming Part D Medicare coverage, out-ofpocket costs for many patients’ medication could be nearly $4000 per year. The cost of multiple physician visits is also high, especially if the patient does not have a primary care physician to optimize referrals and provide care for multiple conditions at each office visit. Patients’ willingness to follow complicated pharmacological regimens may further decline because of high-deductible health insurance. Patients may become increasingly intolerant of overly complex and expensive multidrug regimens and frequent clinic visits when initial costs are paid out of pocket. The implementation of multiple evidence-based clinical recommendations by physicians in office settings is limited both by patient preferences and by physician factors that are poorly understood. The evidence base on which CPGs rest is limited by the number, design, and quality of the underlying clinical trials. Clinical practice guidelines have been reported to be variably flawed in terms of conflict of interest, specialty turf battles, endorsement of new or relatively unproven pharmaceutical agents, and focus on a single condition compared with a broader clinical focus. There is much redundancy and significant variation in recommendations across multiple CPGs for single conditions, such as the 386 diabetes-related CPGs now listed as active at the National Guideline Clearinghouse. Evidence-

Factors influencing psychotropic prescription by non-psychiatrist physicians in a nursing home for the elderly in Brazil.

Adding value to evidence-based clinical guidelines.

A Bone-Hamstring Autograft for Arthroscopic Anterior Cruciate Ligament Reconstruction

Four-Stranded Semitendinosus Tendon Anterior Cruciate Ligament Reconstruction With Mini-invasive Anterolateral Ligament Reconstruction

Anterior cruciate ligament reconstruction using hamstring tendon grafts

Posterior Cruciate Ligament Reconstruction Using Hamstring Tendon Graft with Remnant Augmentation

Editorial Commentary: Gracilis-Sparing Anterior Cruciate Ligament Hamstring Graft Reconstruction Is Less Invasive Than Semitendinosus-Gracilis Graft Harvest, and Shows No Clinical Difference in Outcomes With Grafts Greater Than 8 mm in Diameter

The Effect of Cyclic Knee Motion on the Elongation of Four-Strand Hamstring Autograft in Anterior Cruciate Ligament Reconstruction: an In-Situ Pilot Study

Comparison of clinical outcomes between hamstring tendon autografts and hybrid grafts in ACL reconstruction: a systematic review and meta-analysis

An active-site model of prostaglandin H synthase: an iron "twin-coronet" porphyrin with an aryloxyl radical overhang and its catalytic oxygenation of 1,4-diene.

Hamstring Tendon Regeneration After Harvesting: A Systematic Review

Current concepts of the ecology of chigger-borne rickettsiosis (scrub typhus).

ACL Reconstruction Using Quadrupled Semitendinosus Versus Double-Stranded Semitendinosus and Gracilis Autograft: 2-Year Results From a Prospective Randomized Controlled Study

The effectiveness of quadrupled semitendinosus graft technique in anterior cruciate ligament reconstruction: A network meta-analysis assessing various graft preparation techniques

Periosteal wrapping of the hamstring tendon autograft improves graft healing and prevents tunnel widening after anterior cruciate ligament anatomic reconstruction

Stranded Hamstring Autograft : A Prospective , Randomized Clinical Trial Comparison Between Single-and Double-Bundle Anterior Cruciate Ligament Reconstruction With 6 -

Bicruciate Reconstruction with Bilateral Hamstring Autografts: Technique and Functional Results

Tendon cross‐sectional area on magnetic resonance imaging and anthropometric characteristics can be used to predict insufficient four‐strand hamstring autograft diameter in anterior cruciate ligament reconstruction: A systematic review

MRI STUDY ON TENDON REGENERATION AFTER ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION WITH HAMSTRING TENDON AUTOGRAFTS

A comparison of autogenous patellar tendon and hamstring tendon grafts for anterior cruciate ligament reconstruction

The Promotive Effect of Grafts with the Double-Stranded Peroneus Longus Tendon and with the Four-Stranded Hamstring Tendon on Reconstruction of the Posterior Cruciate Ligament Injury.